AbbVie in the news
ShareCopied to clipboardAnalyze the latest AbbVie news, with a current neutral sentiment polarity (0.05) or the entire set.
Latest news
Here are the latest news on this scope:
Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Beyond the Possible: How AbbVie Uses Technology to Transform Medicines for Patients
Stocks making the biggest moves midday: AbbVie, Tesla, Cigna, Morgan Stanley and more
Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time